Merit Medical Systems, Inc. (MMSI)
Automate Your Wheel Strategy on MMSI
With Tiblio's Option Bot, you can configure your own wheel strategy including MMSI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MMSI
- Rev/Share 23.5654
- Book/Share 24.2529
- PB 3.8583
- Debt/Equity 0.5809
- CurrentRatio 4.8705
- ROIC 0.056
- MktCap 5530235713.0
- FreeCF/Share 3.0246
- PFCF 31.0448
- PE 45.0769
- Debt/Assets 0.3362
- DivYield 0
- ROE 0.0903
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | MMSI | JP Morgan | -- | Overweight | -- | $120 | March 28, 2025 |
| Upgrade | MMSI | Wells Fargo | Equal Weight | Overweight | $103 | $120 | Dec. 11, 2024 |
News
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
Read More
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.
Read More
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
SOUTH JORDAN, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosthesis (CIE) received regulatory approval from Health Canada. With this approval, Merit intends to begin immediate commercialization of the device throughout Canada with devices shipped from Merit's Toronto distribution center.
Read More
LH vs. MMSI: Which Stock Is the Better Value Option?
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
Published: May 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months.
Read More
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.
Read More
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
Published: April 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Merit Medical Stock Slips Despite the Launch of New Ventrax System
Published: April 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
MMSI launches the Ventrax Delivery System, enhancing pulmonary access procedures with improved control, precision, and efficiency for interventionalists.
Read More
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
Read More
Merit Medical (MMSI) Surges 8.3%: Is This an Indication of Further Gains?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Merit Medical (MMSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Merit Medical Launches the Ventrax™ Delivery System
Published: April 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia
Read More
ALGN or MMSI: Which Is the Better Value Stock Right Now?
Published: April 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.
Read More
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
Published: March 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M. (EDT) and the bell ringing takes place at 9:30 A.M.
Read More
First Patient Enrolled in Merit Medical's PREEMIE Study
Published: March 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants
Read More
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Merit Medical (MMSI) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.81 per share a year ago.
Read More
Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now
Published: February 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Read More
About Merit Medical Systems, Inc. (MMSI)
- IPO Date 1990-05-14
- Website https://www.merit.com
- Industry Medical - Instruments & Supplies
- CEO Mr. Fred P. Lampropoulos
- Employees 7400